Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.
Alzheimers Res Ther. 2021 Feb 23;13(1):51. doi: 10.1186/s13195-021-00783-x.
Alzheimers Res Ther. 2021.
PMID: 33622392
Free PMC article.
Clinical Trial.
Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.
Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP.
Phillips MCL, et al. Among authors: gilbertson lj.
Mov Disord. 2018 Aug;33(8):1306-1314. doi: 10.1002/mds.27390. Epub 2018 Aug 11.
Mov Disord. 2018.
PMID: 30098269
Free PMC article.
Clinical Trial.
Item in Clipboard
Long-term outcome of 200 patients referred to a first seizure clinic.
Mc Manus E, Gilbertson L, Timmings P, Lynch C, Asztely F.
Mc Manus E, et al.
Acta Neurol Scand. 2021 Feb;143(2):140-145. doi: 10.1111/ane.13340. Epub 2020 Sep 25.
Acta Neurol Scand. 2021.
PMID: 32885416
Item in Clipboard
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease.
Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM; Protect Study Group.
Snow BJ, et al.
Mov Disord. 2010 Aug 15;25(11):1670-4. doi: 10.1002/mds.23148.
Mov Disord. 2010.
PMID: 20568096
Clinical Trial.
Item in Clipboard
Cite
Cite